Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Liabilities and Shareholders Equity: 2021-2025

Historic Liabilities and Shareholders Equity for Molecular Partners Ag (MOLN) over the last 4 years, with Sep 2025 value amounting to $140,196.

  • Molecular Partners Ag's Liabilities and Shareholders Equity fell 21.23% to $140,196 in Q3 2025 from the same period last year, while for Sep 2025 it was $628,177, marking a year-over-year decrease of 21.76%. This contributed to the annual value of $180,199 for FY2024, which is 18.41% down from last year.
  • According to the latest figures from Q3 2025, Molecular Partners Ag's Liabilities and Shareholders Equity is $140,196, which was down 6.59% from $150,083 recorded in Q2 2025.
  • Over the past 5 years, Molecular Partners Ag's Liabilities and Shareholders Equity peaked at $337,665 during Q1 2022, and registered a low of $140,196 during Q3 2025.
  • In the last 3 years, Molecular Partners Ag's Liabilities and Shareholders Equity had a median value of $188,667 in 2024 and averaged $199,888.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first soared by 45.38% in 2022, then dropped by 27.92% in 2024.
  • Over the past 5 years, Molecular Partners Ag's Liabilities and Shareholders Equity (Quarterly) stood at $187,259 in 2021, then soared by 45.38% to $272,230 in 2022, then decreased by 17.86% to $223,613 in 2023, then decreased by 19.07% to $180,963 in 2024, then fell by 21.23% to $140,196 in 2025.
  • Its Liabilities and Shareholders Equity stands at $140,196 for Q3 2025, versus $150,083 for Q2 2025 and $156,935 for Q1 2025.